Navigation Links
Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
Date:9/19/2007

Adams Seeks to Develop New Prescription Adult Cough Products Using

Lipocine's Proprietary Lip'ral(TM) Technologies

CHESTER, N.J. and SALT LAKE CITY, Sept. 19 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) and Lipocine Inc., a privately- held, leading drug delivery company that uses clinically validated proprietary technologies to address key unmet drug delivery and therapeutics needs, today announced that they have entered into a license and collaboration agreement to develop new prescription adult cough products.

Commenting on the agreement, COO Robert D. Casale said, "This collaboration with Lipocine provides Adams with access to an additional proprietary platform technology and fits with our strategy of taking established compounds and adding increased functionality to create patent- protected, value-added products. The products developed through this collaboration could offer doctors a non-narcotic prescribing option to treat cough with an enhanced dosing regimen. In addition, these products will help Adams compete in the $1.1 billion prescription cough and cold market in the United States."

"Given the large and growing size of the respiratory market, and how patients can benefit from enhanced dosage forms and regimens, we are very pleased to partner with Adams, a company highly respected for its commercialization accomplishments," said Dr. Mahesh Patel, president and CEO of Lipocine Inc.

Lip'ral(TM) and Lip'ral(TM)-SSR are clinically proven oral delivery technologies for water insoluble drugs that improve absorption and can be extended to enable controlled release of insoluble drugs and drugs with pH- sensitive solubility. Multiple patents h
'/>"/>

SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. NanoRite Innovation Center opens with small science, big promise
3. UW-Madison to receive $125M for bioenergy research center
4. WARF enters licensing agreements for stem cell products
5. Internet-enabled niche markets take center stage
6. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
7. TomoTherapy opens technical training center
8. Stem cell and regenerative medicine center to aid education and commerce
9. Mega-Metro Center may go beyond Chicago and Wisconsin
10. Software company enters health space with RFID solutions on hold
11. Former Fiserv exec to enter Business Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 In today,s ... that help them drive positive health outcomes, improve ... source of patient care in their communities. At ... tradeshow and conference, AmerisourceBergen announced a new set ... Services Administration Organization and help independent pharmacies endure ...
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol Market 2015-2019 ... insights on the global resorcinol industry. The report highlights the various growth prospects ... scenarios and analysis of primary and secondary inputs from the existing players of ...
(Date:7/31/2015)... KONG , July 31, 2015 China ... China,s leading provider of cord ... stem cell storage services, today announced that the Company ... the U.S. Securities and Exchange Commission. The filed Form ... ended March 31, 2015. The Form 20-F can be ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud to ... hydrolyzed gluten in foods, has been accepted by AOAC International as Official First ... in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific monoclonal ...
Breaking Biology Technology:AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
... Medical,Innovations, Inc. (Amex: IMA ), a leading provider ... a,dividend of $4.77 per share on its Series B ... paid in shares of Series B,stock in an amount ... divided by,(b) 97% of the average of the volume-weighted ...
... Sept. 15 Assay Designs and the Spinal,Muscular ... a,collaborative agreement for development of reagents and assays ... discovery and development,efforts for spinal muscular atrophy (SMA), ... toddlers. "Assay Designs is excited and proud to,have ...
... Sept. 15 Epeius Biotechnologies,Corporation today announced that ... has been highlighted in a recent NEWS article,published ... (JNCI, Sept. 9,2008). The article, authored by Vickie ... medicine that may succeed where small,molecules and proteins ...
Cached Biology Technology:Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 2Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA) 2Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal 2
(Date:7/31/2015)... The 10 th International Conference on Genomics (ICG-10, ... in Shenzhen , China ... anniversary this year. Since its inauguration in 2006, ICG ... in the ,omics, fields, and is one of the most ... focuses on recent breakthroughs and advances in ,omics, research that ...
(Date:7/27/2015)... July 27, 2015   Zynx Health ™, ... clinical improvement solutions, today announced that its ... available on Android smartphones and tablets. With this ... organizations can use ZynxCarebook to securely exchange messages ... streamline care transitions to other care settings, and ...
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s ... in 2015 that relate to sales of FPC1025 for this smartphone ... MSEK for 2015. Jörgen Lantto, CEO of FPC, comments: ... China and we are proud that ... Axon , its first smartphone ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... CHAMPAIGN, Ill. In two new studies, researchers provide the ... that allow the ribosome the cell,s protein-building machinery ... The first study, in Nature Structural and Molecular Biology ... the insertion process: the moment just after the ribosome docks ...
... (April 17, 2011) Michael Croft, Ph.D., a ... Immunology, has discovered a molecule,s previously unknown role as ... function, making the molecule a promising therapeutic target for ... other lung conditions. A scientific paper on Dr. ...
... , , , , , ... AUDIO: Humpback whales have their own version of the hit single, according to a ... Click here for more information. , , , ... , , , , , ...
Cached Biology News:Researchers get a first look at the mechanics of membrane proteins 2Researchers get a first look at the mechanics of membrane proteins 3La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 3Humpback whale songs spread eastward like the latest pop tune 2Humpback whale songs spread eastward like the latest pop tune 3Humpback whale songs spread eastward like the latest pop tune 4Humpback whale songs spread eastward like the latest pop tune 5
... acid , DTNB , Ellman's reagent ... *CAS-No.: 69-78-3 *Storage: RT, When ... reactive grouping not present in the substrate, it ... will react directly with the product to form ...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... Inhibitor is a recombinant human protein produced in ... neutral pancreatic RNase A type enzymes. The ... binds RNases in a 1:1 ratio. The enzyme ... many tissues and cell types. Addition of the ...
...
Biology Products: